[PDF] Top 20 Multiplicação in vitro de cultivares de amoreira-preta.

... Sloan-Kettering Cancer Center (MSKCC) and Michigan State University reported a thrombosis rate of ...932 patients treated with cisplatin-based regimens for various kinds of ...their ... See full document

... that chemotherapy could increase the risk of DVT/VTE is in accordance with previous studies [15, 18, 22, 24], as well as the risk of DVT/VTE as- sociated with advanced clinical stage [15, ...of ... See full document

... All patients enrolled in the Active Home Care project considered the information received on the oral regimen to be complete and exhaustive, and reported having been informed on the treatment-related ... See full document

... 145 patients with lung, esophageal, uterine, cervical, or ovarian cancer undergoing clinical ...the patients’ renal ...141 patients to clarify the pharmacokinetic profile of nedaplatin and to ... See full document

... tin based radiotherapy and chemotherapy regi- mens have become the standard of treatment for all types of ...of cisplatin and cisplatin com- bined docetaxel chemotherapy with ... See full document

... 14,000 patients were randomly treated with rivaroxaban 20 mg once daily or ...risk patients compared with ...for patients in the warfarin group was in the therapeutic range only 55% of the ...where ... See full document

... RESULTS: Among 1,214 TCS, approximately 20% had a CBM score of high (15%) or very high/severe (4.1%), while almost 80% scored medium (30%) or low/very low (47%). Increased risks of higher scores were associated with 4 ... See full document

... National Cancer Institute (NCI) in Egypt, Zaghloul et ...for patients with MIBC ...East. Another randomized prospective study from the NCI in Egypt compared the use of pre-operative and ... See full document

... Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lym- phocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR) and systemic in fl ammation index (SII) re fl ected the level of systemic in fl ammation in the body. 8,9 ... See full document

... Anticytokine therapy, another novel therapeutic approach, has a limited evidence of efficiency, since only few case reports are available. Cytokines, released by inflammatory cells, damage the muscles that may ... See full document

... consecutive patients with histologically proven primary or metastatic solid tumors who received ...the patients and also by referring to their laboratory data and ...files. Patients underwent ... See full document

... for patients with recurrent and or metastatic squamous cell carcinoma of the head and neck ...the treatment of patients with recurrent squamous cell carcinoma of the head and neck (HNSCC) that is ... See full document

... 28 patients aged ≥ 65 years discon- tinuing chemotherapy because of decreased ...in patients who were previously treated for impaired renal ...fact, patients with UC often have impaired renal ... See full document

... lung cancer (NSCLC) is a leading cause of cancer deaths worldwide ...of patients with advanced NSCLC remains poor despite increased understanding of the disease and therapeutic advances, heightening ... See full document

... neoadjuvant chemotherapy group patients and in ...group patients (P = ...neoadjuvant chemotherapy group (P = ...the patients in the primary surgery arm, while only ...neoadjuvant ... See full document

... ABC patients is critically important in a population who are often unwell from both local (obstructive jaundice, biliary sepsis, bowel obstruction and liver pain) and systemic consequences (malaise, fatigue and ... See full document

... of patients experiencing severe vomiting (de- fined as vomiting five times or more) within 24 h after ...1600 patients, eight treatments plus placebo), except that tropisetron + steroid had the highest ... See full document

... Cytotoxic chemotherapy regimens have been designed to enable the maximum tolerated dose of chemotherapy to be given to optimize cell death using a single dose followed by a period of several weeks to allow ... See full document

... over active control for prevention of CINV over the full 5-day at- risk period in patient populations receiving HEC and MEC specifically for breast, GI/colorectal, and lung cancers, and in populations stratified ... See full document

... second-line chemotherapy in advanced urothelial cancer (Table ...first-line treatment, there is frequently a significant deterioration in performance status (PS) and/or renal function, which makes ... See full document